CytomX reports positive phase 1 data for colorectal cancer treatment
Go back to CytomX reports positive phase 1 data for colorectal cancer treatment| Eaton Vance Dividend Builder Fd Cl C (NASDAQ: CTMX) | Delayed: 3.81 -0.01 (0.26%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $3.82 | 52 Week High | $24.68 | |||
| Open | $3.76 | 52 Week Low | $9.10 | |||
| Day High | $3.89 | P/E | N/A | |||
| Day Low | $3.70 | EPS | $0.00 | |||
| Volume | 3,200,182 | |||||
